Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading SAGE News...
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 13.34% | 15.51 | 14.2% | $283.44m | |
| SHPG | Shire PLC Sponsored ADR | 2.44% | 174.92 | 0.4% | $215.65m | |
| PRGO | Perrigo Co. Plc | 1.79% | 74.64 | 6.4% | $145.95m | |
| PRXL | PAREXEL International Corporation | -0.16% | 87.11 | 7.9% | $127.92m | |
| MNK | Mallinckrodt Plc | 0.04% | 45.39 | 17.7% | $122.33m | |
| ALR | Alere Inc. | 0.17% | 50.23 | 2.7% | $92.00m | |
| JAZZ | Jazz Pharmaceuticals Plc | 3.38% | 159.48 | 2.2% | $81.35m | |
| ENDP | Endo International Plc | 2.37% | 11.65 | 8.9% | $72.74m | |
| UTHR | United Therapeutics Corporation | -0.17% | 131.70 | 13.9% | $71.48m | |
| HZNP | Horizon Pharma plc | 3.85% | 11.87 | 7.6% | $57.22m | |
| AERI | Aerie Pharmaceuticals, Inc. | 1.94% | 55.05 | 8.9% | $55.22m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.69% | 130.57 | 22.1% | $52.43m | |
| MDCO | Medicines Company | -1.75% | 38.15 | 22.3% | $51.45m | |
| ICLR | ICON Plc | 0.25% | 96.63 | 4.2% | $37.33m | |
| CTLT | Catalent Inc | -0.61% | 37.79 | 2.8% | $34.83m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company engages in the development and commercialization of novel medicines to treat central nervous system disorders. Its product candidate includes SAGE-547, which is in clinical development for super-refractory status epileptics; SAGE-217; and SAGE-689, which are in IND-enabling toxicology and safety pharmacology testing. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.,0C58C1-E